Phase 3 Plasma Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group288 enrolled707 locationsNCT03937635
Recruiting
Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RISS Stage I Plasma Cell MyelomaRISS Stage II Plasma Cell MyelomaPlasma Cell Myeloma
ECOG-ACRIN Cancer Research Group1,450 enrolled600 locationsNCT04566328
Recruiting
Phase 3
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
SWOG Cancer Research Network510 enrolled397 locationsNCT05561387
Recruiting
Phase 3
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Fungal InfectionImmunosuppressionDisseminated Histoplasma Capsulatum Infection+1 more
Federal University of Health Science of Porto Alegre279 enrolled5 locationsNCT05814432
Completed
Phase 3Phase 4
Comparing blood levels of two preparations of 2% lignocaine for airway anaesthesia.
plasma lignocaine levelsAirway topicalisation
Department of Anaesthesia, Gosford Hospital42 enrolled1 locationACTRN12620000730909